论文部分内容阅读
新闻背景:2004年2月2日,伴随着新春的喜悦,金蝶国际软件集团主席兼行政总裁徐少春、首席战略官金明、高级副总裁金卓君等一行亲自到访中国医疗设备行业最大的生产企业之一——深圳迈瑞生物医疗电子股份有限公司(以下简称:迈瑞),与迈瑞正式签署了战略合作协议,双方将在 ERP、CRM、BPM、HR 等多个项目和领域上展开全面、深入地合作。这是继去年12月底金蝶与迈瑞签订了百万合同后,双方合作更进一步地推进。在此之前,金蝶国际软件集团在金融行业再次取得战略突破,与中国人民银行总行正式签订了未来两年《合作备忘录》以及首期的百万级销售合同,人民银行决定采用金蝶中间件系统软件产品和服务搭建人行的信息化和电子政务平台。这标志着国产中间件成功突破金融行业的技术壁垒和国外厂商的垄断包围,我国自主知识产权的中间件技术得到政府金融主管机构的大力肯定和支持。
News background: February 2, 2004, along with the joy of New Year, Kingdee International Software Group Chairman and Chief Executive Xu Shaochun, Chief Strategy Officer Jin Ming, Senior Vice President Jin Zhuojun and his party visited China’s medical equipment industry, one of the largest manufacturing enterprises - Shenzhen Mindray Biomedical Electronics Co., Ltd. (hereinafter referred to as Mindray) formally signed a strategic cooperation agreement with Mindray. The two sides will conduct all-round and in-depth cooperation in various fields such as ERP, CRM, BPM and HR. This is the second time in December last year, Kingdee and Mindray signed a million contract, the two sides further promote cooperation. Prior to this, Kingdee International Software Group once again made strategic breakthroughs in the financial industry, formally signed a Memorandum of Cooperation with the People’s Bank of China Head Office and a first-phase million-dollar sales contract in the next two years, and the People’s Bank of China decided to adopt Kingdee Middleware System Software Products and services to build the People’s Bank’s information and e-government platform. This marks that Chinese-made middleware successfully broke through the technical barriers of the financial industry and the monopoly encroachment of foreign manufacturers. The middleware technology of independent intellectual property rights in China has been affirmed and supported by the government financial authorities.